- Randomized Trial of an Early, Standardized Nephrology Consult Triggered by a Machine Learning Model
10:00 AM - 12:00 PM
Randomized Trial of an Early, Standardized Nephrology Consult Triggered by a Machine Learning Model
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Preliminary Phase 2 Results of APX-115, a Pan-NOX Inhibitor in Patients with CKD Undergoing Percutaneous Coronary Intervention for Contrast-Induced AKI
10:00 AM - 12:00 PM
Preliminary Phase 2 Results of APX-115, a Pan-NOX Inhibitor in Patients with CKD Undergoing Percutaneous Coronary Intervention for Contrast-Induced AKI
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Effect of Polymyxin B Hemoadsorption on Mortality in Patients with Endotoxic Septic Shock: The TIGRIS Trial
10:00 AM - 12:00 PM
Effect of Polymyxin B Hemoadsorption on Mortality in Patients with Endotoxic Septic Shock: The TIGRIS Trial
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Evaluating the Efficacy and Safety of HRS-1780 Tablets in Patients with CKD
10:00 AM - 12:00 PM
Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Evaluating the Efficacy and Safety of HRS-1780 Tablets in Patients with CKD
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Evidence of Kidney Benefit with HTD1801 in Patients with Mild Renal Impairment
10:00 AM - 12:00 PM
Evidence of Kidney Benefit with HTD1801 in Patients with Mild Renal Impairment
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Comparison of Patients with Primary Hyperoxaluria 1 and Late-Stage CKD from the BONAPH1DE Registry and ILLUMINATE-C Lumasiran Trial
10:00 AM - 12:00 PM
Comparison of Patients with Primary Hyperoxaluria 1 and Late-Stage CKD from the BONAPH1DE Registry and ILLUMINATE-C Lumasiran Trial
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Extended-Release Calcifediol (ERC) for Secondary Hyperparathyroidism (SHPT) in Chinese Patients with Stages 3 and 4 CKD: A Phase 3 Trial
10:00 AM - 12:00 PM
Extended-Release Calcifediol (ERC) for Secondary Hyperparathyroidism (SHPT) in Chinese Patients with Stages 3 and 4 CKD: A Phase 3 Trial
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- First-in-Human Study of SK-08, a Novel Soluble Guanylyl Cyclase Activator: Safety, Pharmacokinetics, Pharmacodynamics, and Therapeutic Potential for CKD
10:00 AM - 12:00 PM
First-in-Human Study of SK-08, a Novel Soluble Guanylyl Cyclase Activator: Safety, Pharmacokinetics, Pharmacodynamics, and Therapeutic Potential for CKD
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Going with the FLOW: A Large Registry Study on Semaglutide and the Risk of Kidney Complications in Patients with Early Diabetic Kidney Disease
10:00 AM - 12:00 PM
Going with the FLOW: A Large Registry Study on Semaglutide and the Risk of Kidney Complications in Patients with Early Diabetic Kidney Disease
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Improving Kidney Failure Risk Predictions for Clinical Trials Across CKD Stages 1-4
10:00 AM - 12:00 PM
Improving Kidney Failure Risk Predictions for Clinical Trials Across CKD Stages 1-4
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Phase 4, 52-Week, Single-Arm, Post-Marketing Surveillance to Evaluate Safety of Desidustat for Treatment of Anemia in Patients with CKD
10:00 AM - 12:00 PM
Phase 4, 52-Week, Single-Arm, Post-Marketing Surveillance to Evaluate Safety of Desidustat for Treatment of Anemia in Patients with CKD
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Model-Based Vadadustat Starting Dose Recommendations in Patients with Dialysis-Dependent CKD
10:00 AM - 12:00 PM
Model-Based Vadadustat Starting Dose Recommendations in Patients with Dialysis-Dependent CKD
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Vitamin D Metabolome (VDM) Profiles After Single and Repeated Doses of Extended-Release Calcifediol (ERC) in Patients on Hemodialysis (HD)
10:00 AM - 12:00 PM
Vitamin D Metabolome (VDM) Profiles After Single and Repeated Doses of Extended-Release Calcifediol (ERC) in Patients on Hemodialysis (HD)
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Efficacy and Safety of MT1013 vs. Etelcalcetide for Secondary Hyperparathyroidism in Patients on Hemodialysis
10:00 AM - 12:00 PM
Efficacy and Safety of MT1013 vs. Etelcalcetide for Secondary Hyperparathyroidism in Patients on Hemodialysis
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- 52-Week Phase 3 Study to Evaluate the Efficacy and Safety of a Novel Iron-Based Phosphate Binder AP301 in Patients on Dialysis with Hyperphosphatemia
10:00 AM - 12:00 PM
52-Week Phase 3 Study to Evaluate the Efficacy and Safety of a Novel Iron-Based Phosphate Binder AP301 in Patients on Dialysis with Hyperphosphatemia
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Controlled, Randomized Clinical Trial of Personalized Two-Phase Regional Citrate Anticoagulation in Prolonged Intermittent Kidney Replacement Therapy
10:00 AM - 12:00 PM
Controlled, Randomized Clinical Trial of Personalized Two-Phase Regional Citrate Anticoagulation in Prolonged Intermittent Kidney Replacement Therapy
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Reduction in Peritonitis-Related Hospitalization and Catheter Loss with the CloudCath Remote Monitoring System
10:00 AM - 12:00 PM
Reduction in Peritonitis-Related Hospitalization and Catheter Loss with the CloudCath Remote Monitoring System
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Renal Autologous Cell Therapy in Diabetes and CKD
10:00 AM - 12:00 PM
Renal Autologous Cell Therapy in Diabetes and CKD
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Joint Effects of Urine Albumin-to-Creatinine Ratio (UACR) and eGFR on Efficacy and Safety with Simultaneous Initiation of Finerenone and an SGLT2 Inhibitor in the CONFIDENCE Trial
10:00 AM - 12:00 PM
Joint Effects of Urine Albumin-to-Creatinine Ratio (UACR) and eGFR on Efficacy and Safety with Simultaneous Initiation of Finerenone and an SGLT2 Inhibitor in the CONFIDENCE Trial
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Multimodal Kidney Mechanisms of SGLT2 Inhibition in Patients with Type 1 Diabetes
10:00 AM - 12:00 PM
Multimodal Kidney Mechanisms of SGLT2 Inhibition in Patients with Type 1 Diabetes
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Correlation of eGFR and pE-CCL2 in Older Adult Patients Treated with Varoglutamstat: Data from VIVIAD, a Phase 2B Randomized Clinical Trial
10:00 AM - 12:00 PM
Correlation of eGFR and pE-CCL2 in Older Adult Patients Treated with Varoglutamstat: Data from VIVIAD, a Phase 2B Randomized Clinical Trial
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Urinary Proteomic Changes Associated with a Healthier Kidney Phenotype After Dapagliflozin Therapy in Adolescent Patients with Type 1 Diabetes
10:00 AM - 12:00 PM
Urinary Proteomic Changes Associated with a Healthier Kidney Phenotype After Dapagliflozin Therapy in Adolescent Patients with Type 1 Diabetes
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Cardiovascular Risk Prediction Modelling with Semaglutide in Patients with Type 1 Diabetes
10:00 AM - 12:00 PM
Cardiovascular Risk Prediction Modelling with Semaglutide in Patients with Type 1 Diabetes
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Vertical Sleeve Gastrectomy Reprograms Endothelial, Tubular, and Immune Compartments in Youth-Onset Diabetic Kidney Disease
10:00 AM - 12:00 PM
Vertical Sleeve Gastrectomy Reprograms Endothelial, Tubular, and Immune Compartments in Youth-Onset Diabetic Kidney Disease
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Progression of Cardio-Kidney-Metabolic Syndrome in Adolescents with Type 2 Diabetes
10:00 AM - 12:00 PM
Progression of Cardio-Kidney-Metabolic Syndrome in Adolescents with Type 2 Diabetes
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Effect of Plant-Based Diet on BP and Gut Microbiota in Kidney Transplant Recipients (PLANET-KT)
10:00 AM - 12:00 PM
Effect of Plant-Based Diet on BP and Gut Microbiota in Kidney Transplant Recipients (PLANET-KT)
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Relationship of Albuminuria and Renal Artery Stent Outcomes: Results from the FAIR Randomized Clinical Trial
10:00 AM - 12:00 PM
Relationship of Albuminuria and Renal Artery Stent Outcomes: Results from the FAIR Randomized Clinical Trial
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- PHYOX8: Nedosiran in Pediatric Patients with Primary Hyperoxaluria
10:00 AM - 12:00 PM
PHYOX8: Nedosiran in Pediatric Patients with Primary Hyperoxaluria
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Vonafexor in Progressive Alport Syndrome: Early Evidence of Kidney Function Benefit from the ALPESTRIA-1 Trial
10:00 AM - 12:00 PM
Vonafexor in Progressive Alport Syndrome: Early Evidence of Kidney Function Benefit from the ALPESTRIA-1 Trial
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Short-Term Effects of an SGLT2 Inhibitor on Divalent Ions in Patients with ADPKD: The SIDIA Trial
10:00 AM - 12:00 PM
Short-Term Effects of an SGLT2 Inhibitor on Divalent Ions in Patients with ADPKD: The SIDIA Trial
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Linking von Hippel-Lindau Disease and SETD2 in a Common Oncogenic Pathway That Converges on the Mitotic Spindle
10:00 AM - 12:00 PM
Linking von Hippel-Lindau Disease and SETD2 in a Common Oncogenic Pathway That Converges on the Mitotic Spindle
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Multicenter, Randomized Phase 2 Study Evaluating the Efficacy and Safety of HRS-5965 in Patients with Primary IgAN
10:00 AM - 12:00 PM
Multicenter, Randomized Phase 2 Study Evaluating the Efficacy and Safety of HRS-5965 in Patients with Primary IgAN
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Kidney Function Preservation with Belimumab in Patients with Lupus Nephritis Receiving Mycophenolate Mofetil (MMF) Standard Therapy in the BLISS-LN Trial: Improved Proteinuria, Clinical Outcomes, and Biomarkers for Belimumab vs. Placebo
10:00 AM - 12:00 PM
Kidney Function Preservation with Belimumab in Patients with Lupus Nephritis Receiving Mycophenolate Mofetil (MMF) Standard Therapy in the BLISS-LN Trial: Improved Proteinuria, Clinical Outcomes, and Biomarkers for Belimumab vs. Placebo
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Patients (Pts) with FSGS Reach Proteinuria <0.7 g/g More Often with Sparsentan (SPAR) vs. Irbesartan (IRB) in DUPLEX: Implications for Kidney Failure (KF) Risk
10:00 AM - 12:00 PM
Patients (Pts) with FSGS Reach Proteinuria <0.7 g/g More Often with Sparsentan (SPAR) vs. Irbesartan (IRB) in DUPLEX: Implications for Kidney Failure (KF) Risk
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Phase 2 Open-Label Trial Evaluating the Efficacy and Safety of Obinutuzumab (OBI) in Treatment of Immunosuppression-Resistant Primary FSGS, or Contraindication to High-Dose Steroids: A Two-Year Study
10:00 AM - 12:00 PM
Phase 2 Open-Label Trial Evaluating the Efficacy and Safety of Obinutuzumab (OBI) in Treatment of Immunosuppression-Resistant Primary FSGS, or Contraindication to High-Dose Steroids: A Two-Year Study
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Unmasking the Role of Antinephrin Antibodies in FSGS Recurrence After Transplantation: A Multicenter Study from the TANGO Consortium
10:00 AM - 12:00 PM
Unmasking the Role of Antinephrin Antibodies in FSGS Recurrence After Transplantation: A Multicenter Study from the TANGO Consortium
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Acute Dip in eGFR in Patients Treated with Tirzepatide: A Post Hoc Analysis of Long-Term Clinical Trials of Tirzepatide Treatment
10:00 AM - 12:00 PM
Acute Dip in eGFR in Patients Treated with Tirzepatide: A Post Hoc Analysis of Long-Term Clinical Trials of Tirzepatide Treatment
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Population Pharmacokinetic and Exposure-Response Modeling Supports BI 764198 20 mg as the Therapeutic Dose for Phase 3, with No Dose Adjustment Required
10:00 AM - 12:00 PM
Population Pharmacokinetic and Exposure-Response Modeling Supports BI 764198 20 mg as the Therapeutic Dose for Phase 3, with No Dose Adjustment Required
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Dd-cfDNA Predicts Long-Term Graft Outcomes: Kidney Allograft Outcomes AlloSure Registry (KOAR) Results
10:00 AM - 12:00 PM
Dd-cfDNA Predicts Long-Term Graft Outcomes: Kidney Allograft Outcomes AlloSure Registry (KOAR) Results
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Dapagliflozin Treatment Induces Alternate RAAS Activation in Stable Kidney Transplant Recipients
10:00 AM - 12:00 PM
Dapagliflozin Treatment Induces Alternate RAAS Activation in Stable Kidney Transplant Recipients
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Molecular Diagnostics to Facilitate Belatacept Monotherapy in Kidney Transplant Recipients
10:00 AM - 12:00 PM
Molecular Diagnostics to Facilitate Belatacept Monotherapy in Kidney Transplant Recipients
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Potravitug for the Treatment of BK Polyomavirus Infection in Kidney Transplant Recipients: A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
10:00 AM - 12:00 PM
Potravitug for the Treatment of BK Polyomavirus Infection in Kidney Transplant Recipients: A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Patient BK Polyomavirus VP1 Genotyping Predicts Neutralizing Antibody Incompatibility and Provides Guardrails for VP1-Targeting Monoclonal Antibody Trial and Therapy
10:00 AM - 12:00 PM
Patient BK Polyomavirus VP1 Genotyping Predicts Neutralizing Antibody Incompatibility and Provides Guardrails for VP1-Targeting Monoclonal Antibody Trial and Therapy
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Effects of Sodium-Free Chloride Supplementation on Cardiorenal Function in Chronic Heart Failure
10:00 AM - 12:00 PM
Effects of Sodium-Free Chloride Supplementation on Cardiorenal Function in Chronic Heart Failure
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
